Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

JonesTrading Downgrades Concert Pharma to Hold

JonesTrading analyst Sean Kim downgrades Concert Pharma (NASDAQ:CNCE) from Buy to Hold.
byBenzinga Newsdesk
January 20, 2023
1 minute read
Total
0
Shares
0
0
0
0
0
0

JonesTrading analyst Sean Kim downgrades Concert Pharma (NASDAQ:CNCE) from Buy to Hold.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0